Abstract
Temporary vasoactive reddening of the skin is called flushing.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Bibliography: Erythematous and Erythematosquamous Skin Diseases
Flushing
Blaich W, Engelhardt H (1951) Intermittierende Erythembildung als Ausdruck syndromatischer Verknüpfung bestimmter Hautveränderungen mit einer Polyneuroradikulitis ( Guillain-Barré ). Dermatol Wochenschr 123: 289–297
Eaton AC, McGuire N (1983) Cyproterone acetate in treatment of post-orchidectomy hot flushes. Lancet II: 1336–1337
Edington RF, Chagnon JP, Steinberg WM (1980) Clonidine for menopausal flushing. Can Med J 123: 23–26
Lightman SL, Jacobs HS (1979) Naloxone: non-steroidal treatment for postmenopausal flushing? Lancet II: 1071
Wilkin JK (1983) Flushing reactions. In: Rook AJ, MaibachHI (eds) Recent advances in dermatology, vol 6. Churchill Livingstone, Edinburgh, pp 157–187
Flushing in Carcinoid Syndrome
Degos R, Touraine R, Godeau Pet al. (1972) Les manifestations cutanées du syndrome carcinoidin. Ann Dermatol Syph (Paris) 99: 243–255
Kühler HJ, Heilmeyer L (1961) VII. Klinik und Pathophysiologie des Karzinoids und Karzinoidsyndroms unter besonderer Berücksichtigung der Pharmakologie des 5Hydroxytryptamins. Ergeb Inn Med Kinderheilkd 16: 292–559
Kierland RR, Sauer WG, Dearing WH (1958) The cutaneous manifestations of the functioning carcinoid. Arch Dermatol Syphilol 77: 86–90
Melmon K (1968) Kinins — one of many mediators of the carcinoid spectrum. Gastroenterology 55: 545–548
Melmon KL, Sjoerdsma A, Mason DT (1965) Distinctive clinical and therapeutic aspects of the syndrome associated with bronchial carcinoid tumors. Am J Med 39: 568–581
Roberts JL, Marney SR, Oates JA (1979) Blockade of the flush associated with metastatic gastric carcinoid by combined HI and H2 receptor antagonists. Evidence for an important role of H2 receptors in human vasculature. N Engl J Med 300: 236–238
Smith AG, Greaves MW (1974) Blood prostaglandin activity associated with noradrenaline-provoked flush in the carcinoid syndrome. Br J Dermatol 90: 547–551
Erythema Toxicum Neonatorum
Freeman RG, Spiller R, Knox JM (1960) Histopathology of erythema toxicum neonatorum. Arch Dermatol 82: 586–589
Hansen LP, Brandrup F, Zori R (1985) Erythema toxicum neonatorum mit Pustulation versus transitorische neonatale pustulöse Melanose. Hautarzt 36: 475–477
Pohlandt F, Harnisch R, Meigel WN et al. (1977) Zum Bild des Erythema neonatorum. Hautarzt 28: 469–474
Erythema Dyschromicum Perstans
Jablonska S, Chorzelski T (1975) Ingestion of ammonium nitrate as a possible cause of erythema dyschromicum perstans (ashy dermatosis). Dermatologica 150: 287–291
Knox JM, Dodge BG, Freeman RG (1968) Erythema dyschromicum perstans. Arch Dermatol 97: 262–272
Müller-Vietheer M, Goos M (1977) Erythema dyschromicum perstans. Hautarzt 28: 539–541
Novick NL, Phelps R (1985) Erythema dyschromicum perstans. Int J Dermatol 24: 630–633
Peachy RDG (1976) Ashy dermatosis. Br J Dermatol 94: 227–228
Stevenson MJR, Miura M (1966) Erythema dyschromicum perstans ( Ashy dermatosis ). Arch Dermatol 94: 196–199
Tschen JA, Tschen EA, McGavran MH (1980) Erythema dyschromicum perstans. J Am Acad Dermatol 2: 295–302
Figurate Erythemas
Hurley H, Hurley JP (1984) The gyrate erythemas. Semin Dermatol 3: 327–336
Saurat JH, Janin-Mercier A (1984) Infantile epidermodysplastic erythema gyratum responsive to imidazoles. A new entity? Arch Dermatol 120: 1601–1603
White JW Jr (1985) Gyrate erythema. (Symposium on urti-caria and the reactive inflammatory vascular dermatoses). Dermatol Clin III: 129–139
Bressler GS, Jones RE Jr (1981) Erythema annulare centrifugum. J Am Acad Dermatol 4: 597–602
Darier J (1916) De l’érythème annulaire centrifuge (érythème papulo-circiné migrateur et chronique) et de quelques éruptions analogues. Ann Dermatol Syph (Paris) 6: 57–76
Hendricks A, Lu C, Elfenbein GJ et al. (1981) Erythema annulare centrifugum associated with ascariasis. Arch Dermatol 117: 582–585
Jillson D (1954) Allergic confirmation that some cases of erythema annulare centrifugum are dermatophtids. Arch Dermatol Syphilol 70:355–359
Kikuchi I, Ogata K, Inoue S (1984) Pityrosporum infection in an infant with lesions resembling erythema annulare centrifugum. Arch Dermatol 120: 380–382
Korting GW, Eissner H (1958) Beitrag zur teleangiektatischen und purpurischen Erscheinungsform des Erythema centrifugum anulare ( Typus Gougerot und Patte ). Dermatol Wochenschr 138: 854–863
Mahood JM (1983) Erythema annulare centrifugum. A review of 24 cases with special reference to its association with underlying disease. Clin Exp Dermatol 8:383–387 Shelley WB (1965) Erythema annulare centrifugum due to Candida albicans. Br J Dermatol 77: 383–384
Gammel JA (1952) Erythema gyratum repens — skin manifestations in a patient with carcinoma of breast. Arch Dermatol Syphilol 66: 494–505
Holt PJA, Davies MG (1977) Erythema gyratum repens — an immunologically mediated dermatosis. Br J Dermatol 96: 343–347
Pevny I (1966) Erythema gyratum repens. Z Hautkr 40: 260–270
Thomson J, Stankler L (1970) Erythema gyratum repens. Reports of two further cases associated with carcinoma. Br J Dermatol 82: 406–411
Verret J, Schnitzler L, Schubert B et al. (1979) Erythema gyratum repens ( Gammel-Syndrom ). Hautarzt 30: 213–215
Yebra-Sotillo I, Garcia-Bravo B, Camacho-Martinez F et al. (1983) Erythema gyratum repens de Gammel y enfermedad de Hodgkin. Med Cutan Ibero Lat Am 11: 281
Beare JM, Frogatt P, Jones JH (1966) Familial annular erythema. An apparently new dominant mutation. Br J Dermatol 78: 59–68
Friedman StJ, Winkelmann RK (1987) Familial granuloma annulare. Report of two cases and review of the literature. J Am Acad Dermatol 16: 600–605
Burke JB (1955) Erythema marginatum. Arch Dis Child 30: 359–365
Gadrat J (1938) Sur les érythèmes rhumatismaux. Ann Dermatol Syphiligr 9: 1045–1051
Greither A (1957) Über das Erythema annulare rheumaticum. Arch Klin Exp Dermatol 204: 205–212
Keil H (1938) The rheumatic erythemas: a critical survey. Ann Intern Med 11: 2223–2272
Okoroma EO, Ihenacho IN, Anyanwu CH (1981) Rheumat- ic fever in Nigerian children. Am J Dis Child 135: 236–238
Ueki H, Oka D, Takei Y et al. (1981) Erythema rheumati-cum. Hautarzt 32: 425–428
Becker SW, Kahn D, Rothman S (1942) Cutaneous manifestations of internal malignant tumors. Arch Dermatol Syphilol 45: 1069–1080
Binnick AN, Spencer SK, Dennison LW et al. (1977) Glucagenoma syndrome. A report of two cases and literature review. Arch Dermatol 113: 749–754
Doyle JA, Schroeter AL, Rogers RS III (1979) Hyperglucagonemia and necrolytic migratory erythema in cirrhosis — possible pseudoglucagonoma syndrome. Br J Dermatol 101: 581–587
Galle H, Schweiss D (1984) Das Glukagonom-Syndrom — eine wenig bekannte kutane Paraneoplasie. Hautarzt 35: 204–209
Kheir SM, Omura EF, Grizzle WE, Herrera GA et al. (1986) Histologic variation in the skin lesions of the glucagonoma syndrome. Am J Surg Pathol 10: 445–453
Leichter SB (1980) Clinical and metabolic aspects of the glucagonoma. Medicine (Baltimore) 59: 100–113
Leichter SB (1986) Glucagonoma: an endocrine neoplasm with a unique dermatosis — necrolytic migratory erythema. In: Jelinek JE (ed) The skin in diabetes. Lea and Febiger, Philadelphia, pp 143–153
Mallinson CN, Bloom SR, Warin AP et al. (1974) A glucagonoma syndrome. Lancet II: 1–5
Röckl H, Metz J, Ackermann-Schopf C (1977) Staphylodermia superficialis circinata. Die 5. obligate kutane Para-neoplasie. Hautarzt 28: 178–184
Vandersteen PR, Scheithauer BW (1985) Glucagonoma syndrome. A clinicopathologic, immunocytochemical, and ultrastructural study. J Am Acad Dermatol 12:1032–1039 Wilkinson DS (1971) Necrolytic migratory erythema with pancreatic carcinoma. Proc R Soc Med 64: 1197–1198
Buhles N, Altmeyer P (1984) Erythema elevatum diutinum bei Frühsyphilis. Aktuel Dermatol 10: 211–212
Cream JJ, Levene GM, Calnan CD (1971) Erythema eleva-turn diutinum. Br J Dermatol 84: 393–399
Haber H (1955) Erythema elevatum diutinum. Br J Dermatol 67: 121–145
Katz SI, Gallin JI, Hertz KC et al. (1977) Erythema eleva-turn diutinum. Skin and systemic manifestations, immunologic studies, and successful treatment with Dapsone. Medicine (Baltimore) 56: 443–455
Kint A, De Cuyper C (1980) Erythema elevatum diutinum. Hautarzt 31: 447–449
LeBoit PE, Yen TSB, Wintroub B (1986) The evolution of lesions in erythema elevatum diutinum. Am J Dermatopathol 8: 392–402
Wolff HH, Maciejewsky W, Scherer R (1978) Erythema elevatum diutinum. I. Electron microscopy of a case with extracellular cholestosis. Arch Dermatol Res 261: 7–16
Wolff HH, Scherer R, Maciejewski Wet al. (1978) Erythema elevatum diutinum. II. Immunoelectronmicroscopical study of leukocytoclastic vasculitis within the intracutaneous test reaction induced by streptococcal antigen. Arch Dermatol Res 261: 17–26
Erythema Multiforme
Bedi TR, Pinkus H (1976) Histopathological spectrum of erythema multiforme. Br J Dermatol 95: 243–250
Braun-Falco O, Bandmann JH (1970) Das Lyell-Syndrom. Huber, Bern
Duvic M, Reisner EG, Dawson DV et al. (1983) HLA-B15 association with erythema multiforme. J Am Acad Dermatol 8: 493–496
Elias PM, Fritsch PO (1987) Erythema multiforme. In: Fitzpatrick TB, Eisen AZ, Wolff K et al. (eds) Dermatology in general medicine, 3rd edn. McGraw-Hill, New York, pp 555–562
Galosi A, Plewig G, Hölzle E et al. (1986) Lichtinduziertes postherpisches Erythema exsudativum multiforme. Hautarzt 37: 494–498
Kleibl K, Rehàk A, Szàntò J (1975) Erythema exsudativum multiforme postherpeticum. Dermatol Monatsschr 161: 293–299
Lemak MA, Davis M, Bean SF (1986) Oral acyclovir for the prevention of herpes-associated erythema multiforme. J Am Acad Dermatol 15: 50–54
Lepage V, Douay C, Mallet C et al. (1988) Erythema multiforme is associated with HLA-Aw33 and DRw53. Tissue Antigens 32: 170–175
Lozada F, Spitler L, Silverman S Jr (1980) Results of immunologic testing in patients with erythema multiforme. J Dent Res 59: 567–572
Lyell A (1979) Toxic epidermal necrolysis (the scalded skin syndrome): a reappraisal. Br J Dermatol 100: 69–86
Lyell A, Gordon AM, Dick HM (1967) Mycoplasmas and erythema multiforme. Lancet II: 1116–1118
Nethercott JR, Choi BCK (1985) Erythema multiforme (Stevens-Johnson-Syndrome) — chart of 123 hospitalized patients. Dermatologica 171: 383–396
Proppe A (1949) Die Baader’sche Dermatostomatitis, die Ektodermisis erosiva pluriorificialis Fiessinger und Rendu, das Stevens-Johnson-Syndrom und die Conjunctivitis et Stomatitis pseudo-membranacea als Syndroma mucocutaneo-oculare acutum Fuchs. Arch Dermatol Syph 60: 392–408
Shelley WB (1967) Herpes simplex virus as a cause of erythema multiforme. JAMA 201: 153–156
Wuepper KD, Watson PA, Katzmierowski JA (1980) Immune complexes in erythema multiforme and Stevens-Johnson syndrome. J Invest Dermatol 74: 368–371
Kawasaki’s Disease
Bligard CA (1987) Kawasaki disease and its diagnosis. Pediatr Dermatol 4: 75–84
Burns JC, Geha RS, Schneeberger EE et al. (1986) Polymerase activity in lymphocyte culture supernatants from patients with Kawasaki disease. Nature 323: 814–816
Capannari TE, Daniels SR, Meyer RA et al. (1986) Sensitivity, specificity and predictive value of two-dimensional echocardiography in detecting coronary artery aneurysms in patients with Kawasaki disease. J Am Coll Cardiol 7: 355–360
Everett ED (1979) Mucocutaneous lymph node syndrome (Kawasaki disease) in adults. JAMA 242: 542–543
Friter BS, Lucky AW (1988) The perineal eruption of Kawa- saki syndrome. Arch Dermatol 124: 1805–1810
Hirose S, Hamashima Y (1978) Morphological observations on the vasculitis in the mucocutaneous lymph node syndrome. A skin biopsy of 27 patients. Eur J Pediatr 129: 17–27
Kawasaki T (1967) Acute febrile mucocutaneous lymph node syndrome: clinical observation of 50 cases. Jpn J Allergy 16: 178–222 (in Japanese)
Kawasaki T, Kosaki F, Owaka S et al. (1974) A new infantile, acute febrile mucocutaneous lymph node syndrome ( MLNS) prevailing in Japan. Pediatrics 54: 271–276
Kimura T, Miyazawa H, Watanabe K et al. (1988) Small pustules in Kawasaki disease. A clinicopathological study of four patients. Am J Dermatopathol 10: 218–223
Newburger JW, Takahashi M, Burns JC et al. (1986) The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 315: 341–347
Rodermund OE (1983) Das Kawasaki-Syndrom (mukokutanes Lymphknotensyndrom). In: Braun-Falco 0, Burg G (eds) Fortschritte der praktischen Dermatologie and Venerologie, vol 10. Springer, Berlin, pp 395–398
Suzuki A, Kamiya T, Kuwahara N et al. (1986) Coronary arterial lesions of Kawasaki disease: cardiac catheterization findings of 1100 cases. Pediatr Cardiol 7: 3–10
Taylor JFN (1987) Kawasaki’s disease. Br Med J 294: 137–138
Weston WL, Huff JC (1981) The mucocutaneous lymph node syndrome: a critical re-examination. Clin Exp Dermatol 6: 167–168
Erythema Nodosum
Bäfverstedt BO (1954) Erythema nodosum migrans. Acta Derm Venereol (Stockh) 48: 381–384
Blomgren SE (1974) Erythema nodosum. Semin Arthritis Rheum 4: 1–24
Hannuksela M (1973) Erythema nodosum migrans. Acta Derm Venereol (Stockh) 53: 313–317
Hannuksela M (1977) Human yersinoisis: a common cause of erythematous skin eruptions. Int J Dermatol 16: 665
Korting HC, Tröscher W (1978) Arthritis und Erythema nodosum als typische Manifestation einer Yersiniaenterocolitica-Infektion. Med Welt 29: 1754–1758
Löfgren S (1946) Erythema nodosum. Studies on etiology and pathogenesis in 185 adult cases. Acta Med Scared Suppl 174: 1–197
Miescher G (1947) Zur Histologie des Erythema nodosum. Acta Derm Venereol (Stockh) 27: 447–468
Perry HO, Winkelmann RK (1964) Subacute nodular migratory panniculitis. Arch Dermatol 89: 170–179
Röckl H, Metz J (1973) Nodöse Erytheme. In: Braun-Falco O, Petzoldt D (eds) Fortschritte der praktischen Dermatologie und Venerologie, vol 7. Springer, Berlin, pp 196–205
Röckl H, Metz J, Amschler A (1979) Erythema nodosum. Allergologie 2: 72–77
Schweier P (1968) Zur Atiologie des Erythema nodosumim Kindesalter. Munch Med Wochenschr 110: 544–547
Soderstrom RM, Krull EA (1978) Erythema nodosum: areview. Cutis 21: 806–810
Vilanova X, Pinol Aguadè J (1959) Subacute nodular migratory panniculitis. Br J Dermatol 71: 45–50
White JW (1985) Erythema nodosum. Dermatol Clin Ill: 119–127
Winkelmann RK, Förström L (1975) New observations in the histopathology of erythema nodosum. J Invest Dermatol 65: 441–446
Acute Febrile Neutrophilic Dermatosis
Cooper PH, Innes DJ, Greer KE (1983) Acute febrile neutrophilic dermatosis ( Sweet’s syndrome) and myeloproliferative disorders. Cancer 51: 1518–1526
Crow KD, Kerdel-Vegas F, Rook A (1969) Acute febrile neutrophilic dermatosis: Sweet’s syndrome. Dermatologica 139: 123–134
Hofmann C, Braun-Falco O, Petzoldt D (1976) Akute febrile neutrophile Dermatose ( Sweet-Syndrom ). Dtsch Med Wochenschr 101: 1113–1118
Matta M, Malak J, Tabet E et al. (1973) Sweet’s syndrome: systemic association. Cutis 12: 561–565
Moschella SL (1983) Review of so-called aseptic neutrophilic dermatoses. Aust J Dermatol 24: 55–62
Pachinger W, Rauch H-J (1984) Lokalisiertes Sweet-Syndrom. Aktuel Dermatol 10: 209–210
Storer JS, Nesbitt LT, Galen WK et al. (1983) Sweet’s syndrome: a review. Int J Dermatol 22: 8–12
Sweet RD (1964) An acute febrile neutrophilic dermatosis. Br J Dermatol 76: 349–356
Sweet RD (1979) Acute febrile neutrophilic dermatosis —1978. Br J Dermatol 100: 93–99
Tikjob G, Kassis V, Klem Thomsen H et al. (1985) Acute febrile neutrophilic dermatosis and abnormal bone marrow chromosomes as a marker for preleukemia. Acta Derm Venereol (Stockh) 65: 177–179
Pityriasis Rosea
Aoshima T, Komura J, Ofiji S (1981) Virus-like particles in the herald patch of pityriasis rosea. Dermatologica 162: 64–65
Björnberg A (1987) Pityriasis rosea. In: Fitzpatrick TB, Eisen AZ, Wolff K et al. (eds) Dermatology in general medicine. McGraw-Hill, New York, pp 982–990
Björnberg A, Hellgren L (1962) Pityriasis rosea: a statistical, clinical and laboratory investigation of 826 patients and matched healthy controls. Acta Derm Venereol (Stockh) 42 (Suppl 50): 1–68
Bonafé J-L, Icart J, Perpère M et al. (1982) Étude histopathologique, ultrastructurale, immunologique et virologique du pityriasis rosé de Gibert. Ann Dermatol Vénéreo1109: 855–861
Bunch LW, Tilley JC (1961) Pityriasis rosea. A histologic and serologic study. Arch Dermatol 84: 79–86
Chuang T, Ilstrup DM, Perry HO et al. (1982) Pityriasis rosea in Rochester, Minnesota, 1969 to 1978. A 10 year epidemiologic study. J Am Acad Dermatol 7: 80–89
Feinstein A, Kahana M (1987) Pityriasis rosea of Gibert. J Am Acad Dermatol 15: 1260
Gibert CM (1860) Traité Pratique des Maladies de la peau et de la Syphilis, 3rd edn. Plon, Paris, pp 402
Metz J (1977) An electron microscopic investigation of the pityriasis rosea. J Cutan Pathol 4: 228
Panizzon R, Bloch PH (1982) Histopathology of pityriasis rosea Gibert. Qualitative and quantitative lightmicroscopic study of 62 biopsies of 40 patients. Dermatologica 165: 551–558
Parsons JM (1986) Pityriasis rosea update: 1986. J Am Acad Dermatol 15: 159–167
Percival GH (1932) Pityriasis rosea. Br J Dermatol 44: 241–253
Raskin J (1968) Possible dermatotrophic virus associated with pityriasis rosea. Preliminary study. Acta Derm Venereol (Stockh) 48: 474–481
Psoriasis
Baden HP (ed) (1984) The chemotherapy of psoriasis. International encyclopedia of pharmacology and therapeutics, section 110. Pergamon, New York
Beutner EH (ed) (1982) Autoimmunity in psoriasis. CRC, Boca Raton
Bos JD (1988) The pathomechanism of psoriasis; the skin immune system and cyclosporin. Br J Dermatol 118: 141–155
Christophers E, Krueger GG (1987) Psoriasis. In: Fitzpatrick TB, Eisen AZ, Wolff K et al. (eds) Dermatology in general medicine, 3rd edn. McGraw-Hill, New York, pp 461–491
Cram DL (1981) Psoriasis: current advances in etiology and treatment. J Am Acad Dermatol 4: 1–14
Farber EM, Cox AJ (1971) Psoriasis. Proceedings of the international symposium. Stanford University, 1971. Stanford University Press, Stanford
Farber EM, Cox AJ, Jacobs PH et al. (eds) (1977) Psoriasis. Proceedings of the second international symposium. Yorke Medical, New York
Farber EM, Cox AJ, Nall L et al. (eds) (1982) Psoriasis. Proceedings of the third international symposium. Grune and Stratton, New York
Kröger H, Stüttgen G (eds) (1984) Current research problems in psoriasis. Grosse, Berlin
Kulick KB, Mogavero H Jr, Provost TT et al. (1983) Serologic studies in patients wth lupus erythematosus and psoriasis. J Am Acad Dermatol 8: 631–634
Roenigk HH, Maibach HI (eds) (1985) Psoriasis. Dekker, New York
Wright NA, Camplejohn RS (eds) (1983) Psoriasis: cell proliferation. Churchill Livingstone, Edinburgh
Christophers E, Henseler T (1985) Characterization of disease patterns in nonpustular psoriasis. Semin Dermatol 4: 271–275
Farber EM, Nall ML, Watson W (1974) Natural history of psoriasis in 61 twin pairs. Arch Dermatol 109:207–211 Henseler T, Christophers E (1985) Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol 13: 450–456
Karvonen J (1975) HL-A antigens in psoriasis with special reference to the clinical type, age of onset, exacerbations after respiratory infections and occurrence of arthritis. Ann Clin Res 7: 301–311
Karvonen J, Tiilikainen A, Lassus A (1975) HL-A antigens in patients with persistent palmoplantar pustulosis and pustular psoriasis. Ann Clin Res 7: 112–115
Lerner MR, Lerner AB (1972) Congenital psoriasis. Arch Dermatol 105: 598–602
Lomholt G (1963) Psoriasis: prevalence, spontaneous course and genetics. A census study on the prevalence of skin diseases on the Faroe Islands. G.E.C. GAD, Copenhagen
Lomholt G (1971) Environment and genetics in psoriasis. In: Farber EM, Cox AJ (eds) Psoriasis: international symposium. Stanford University Press, Stanford, pp 2124
Schoefinius HH, Braun-Falco O, Scholz S et al. (1974) Histokompatibilitätsantigene (HL-A) bei Psoriasis. Untersuchungen an 104 unverwandten Patienten. Dtsch Med Wochenschr 99: 440–444
Watson W, Cann HM, Farber EM et al. (1972) The genetics of psoriasis. Arch Dermatol 105: 197–207
Woodrow JC, Dave VK, Usher N et al. (1975) The HL-A-system and psoriasis. Br J Dermatol 92: 427–436
Baker H, Ryan TJ (1968) Generalized pustular psoriasis. A clinical and epidemiological study of 104 cases. Br J Dermatol 80: 771–793
Braun-Falco O, Berthold D, Ruzicka T (1987) Psoriasis pustulosa generalisata — Klassifikation, Klinik und Therapie. Übersicht und Erfahrungen an 18 Patienten. Hautarzt 38: 509–520
Pierard J, Kint A (1978) La pustulose palmo-plantaire chronique et récidivante. Ann Dermatol Venereol 105: 681–688
Shelnitz LS, Esterly NB, Honig PJ (1987) Etretinate therapy for generalized pustular psoriasis in children. Arch Dermatol 123: 230–233
Uehara M, Ofuji S (1974) The morphogenesis of pustulosis palmaris et plantaris. Arch Dermatol 109: 518–520
Baker H, Fry L, Pegum JS (1973) Psoriasis. In: Rook A (ed) Recent advances in dermatology, vol 3. Churchill Livingstone, Edinburg, pp 411–450
Braun-Falco 0 (1958) The histochemistry of psoriasis. Ann NY Acad Sci 73: 936–976
Braun-Falco O (1963) Zur Morphogenese der psoriatischen Hautreaktion. Eine morphologisch-histochemische Studie. Arch Klin Exp Dermatol 216: 130–154
Braun-Falco 0 (1971) Dynamics of growth and regression in psoriatic lesions. In: Farber EM, Cox AJ (eds) Psoriasis. Stanford University Press, Stanford, pp 215–237
Braun-Falco 0 (1976) Neuere Aspekte zur Pathogenese der Hauterscheinungen bei Psoriasis vulgaris. Hautarzt 27: 363–374
Braun-Falco O, Christophers E (1974) Structural aspects of initial psoriatic lesions. Arch Dermatol Forsch 251: 95110
Braun-Falco O, Burg G, Farber EM (1972) Psoriasis — eine Bibliography: Erythematous and Fragebogenstudie an 536 Patienten. Münch Med Wochenschr 114: 1105–1110
Cox AJ, Watson W (1972) Histological variations in lesions of psoriasis. Arch Dermatol 106: 503–506
Jablonska S, Beutner EH, Binder WL et al. (1979) Immuno- pathology of psoriasis. Arch Dermatol Res 264: 65–71
Krüger A (1986) Retroviruses and psoriasis vulgaris. ZHautkr 61: 1585–1588
Lazar AP, Roenigk HH (1987) Aids and psoriasis. Cutis 39: 347–351
Nickoloff BJ (1987) Interferons and psoriasis — 1987 perspective. Dermatologica 175: 1–4
Ragaz A, Ackerman AB (1979) Evolution, maturation and regression of lesions of psoriasis. Am J Dermatopathol 1: 199–214
Soltani K, Van Scott EJ (1972) Patterns and sequence of tissue changes in incipient and envolving lesions of psoriasis. Arch Dermatol 106: 484–490
Vorhees JJ (1978) Regulation of epidermal proliferation and differentiation in psoriasis. J Dermatol 5: 241–255
Braun-Falco O, Rassner G (1969) Psoriasis arthropathica aus dermatologischer Sicht. Therapiewoche 19: 261–265
Holzmann H, Hoede N, EiBner D et al. (1979) Die psoriatische Osteoarthropathie. Hautarzt 30: 343–348
Sönnichsen N (1971) Zur Pathogenese und nosologischen Stellung der Psoriasis arthropathica. Hautarzt 22: 222–228
Taggert A, Wright V (1987) Psoriatic arthritis. In: Fitzpatrick TB, Eisen AZ, Wolff K et al. (eds) Dermatology in general medicine, 3rd edn. McGraw-Hill, New York, pp 491–501
Wright V (1961) Psoriatic arthritis. Ann Rheum Dis 20: 123–140
Abel EA, DiCicco LM, Orenberg EK et al. (1986) Drugs in exacerbation of psoriasis. J Am Acad Dermatol 15: 1007–1022
Abels DJ, Kattan-Byron J (1985) Psoriasis treatment at the Dead Sea: a natural selective ultraviolet phototherapy. J Am Acad Dermatol 12: 639–643
Baden HP (ed) (1984) The chemotherapy of psoriasis. International encyclopedia of pharmacology and therapeutics, section 110. Pergamon, New York
Bishop SC (1979) DNA repair synthesis in human skin exposed to ultraviolet radiation used in PUVA (psoralen and UV-A) therapy for psoriasis. Br J Dermatol 101: 399–405
Braun-Falco O, Galosi A, Ruzicka T (1987) Was ist gesichert in der Behandlung der Psoriasis? Internist 28: 58–64
Brodi I, Johansson A (1977) A topical treatment program for psoriasis with low anthralin concentrations. J Cutan Pathol 4: 233–243
Cram DL (1981) Psoriasis: current advances in etiology and treatment. J Am Acad Dermatol 4: 1–14
Elbracht C, Landes E (1983) Untersuchung über die Wirksamkeit einer kombinierten Psoriasis-Behandlung mit Dithranol and UV-B ( SUP ). Z Hautkr 58: 387–397
Ellis CN, Fallon JD, Kang S et al. (1986) Topical application of nonsteroid anti-inflammatory drugs prevents vehicle-induced improvement of psoriasis. J Am Acad Dermatol 14: 39–43
Ellis CN, Goldfarb MT, Roenigk HH et al. (1986) Effects of oral meclofenamate therapy in psoriasis. J Am Acad Dermatol 14: 49–52
Ellis CN, Gorsulowsky DC, Hamilton TA et al. (1986) Cyclosporine improves psoriasis in a double-blind study. JAMA 256: 3110–3116
Ellis CN, Voorhees JJ, Arbor A (1987) Etretinate therapy. J Am Acad Dermatol 16: 267–291
Engst R, Fries P (1985) Klimatherapie der Psoriasis: Kritische Wertung. Hautarzt 36: 54–58
Farber EM, Harris DR (1970) Hospital treatment of psoriasis. A modified anthralin program. Arch Dermatol 101: 381–389
Farber EM, Abel EA, Charuworn A (1983) Recent advances in the treatment of psoriasis. J Am Acad Dermatol 8: 311–321
Frost P, Horwitz SN, Caputo RV (1979) Tar gel phototherapy for psoriasis. Arch Dermatol 115: 840–847
Glinski W, Jablonska S, Imiela J et al. (1985) Peritoneal-dialyse und Leukopherese bei Psoriasis: Indikation und Kontraindikation. Hautarzt 36: 16–19
Goerz G, Merk H, Hölzle E (1985) Teerbehandlung der Psoriasis. Hautarzt 36: 50–53
Gollnick H, Orfanos CE (1985) Etretinat: Pro und Contra. Nutzen-Risiko-Abwägung der systemischen Retinoidtherapie bei Psoriasis und neuere Entwicklungen: Freie aromatische Säure, Arotinoide. Hautarzt 36: 2–9
Halprin KM (1984) Treatment of psoriasis. J Dermatol 11: 419–424
Heidbreder G, Christophers E (1979) Therapy of psoriasis with retinoid plus PUVA: clinical and histological data. Arch Dermatol 264: 331–337
Henseler T, Christophers E, Hönigsmann H (1987) Skin tumors in the European PUVA Study. Eight year follow-up of 1643 patients treated with PUVA for psoriasis. J Am Acad Dermatol 16: 108–116
Hofmann C, Plewig G, Braun-Falco 0 (1976) Klinische Erfahrungen mit der 8-Methoxypsoralen-UVA-Therapie ( Photochemotherapie) bei Psoriasis. Hautarzt 27: 588–594
Hofmann C, Neiß A, Plewig G et al. (1980) Orale 8-Methoxypsoralen-UVA-(PUVA-)Therapie bei Psoriasis: Vergleich dreier Behandlungsprotokolle. Hautarzt 31: 315–323
Ingram JT (1953) The approach to psoriasis. Br Med J 2: 591–594
LeVine MJ, White HAD, Parrish JA (1978) Components of the Gloeckerman regimen for psoriasis. Br J Dermatol 98: 437–444
Lowe NJ, Wortzman MS, Breeding J et al. (1983) Coal tar phototherapy for psoriasis reevaluated: erythemogenic versus suberythemogenic ultraviolet with a tar extract in oil and crude coal tar. J Am Acad Dermatol 8: 781–789
Mahrle G, Schulze HJ, Steigleder GK (1985) Dithranol und kombinierte Behandlungsverfahren: Pro und Contra. Hautarzt 36: 34–39
Marghescu S (1985) Die örtliche Behandlung der Psoriasis mit Glukokortikosteroiden. Hautarzt 36: 47–49
Marks JM (1986) Cyclosporin A treatment of severe psoriasis. Br J Dermatol 115: 745–746
Menter A, Cram DL (1983) The Goeckerman regimen in two psoriasis day care centers. J Am Acad Dermatol 9: 59–65
Orfanos CE, Gollnick H, Bauer R et al. (1983) Orale Retinoidtherapie der Psoriasis. In: Braun-Falco O, Burg G (eds) Fortschritte der praktischen Dermatologie und Venerologie, vol 10. Springer, Berlin, pp 55–101
Parrish J, Fitzpatrick TB, Tannenbaum L et al. (1974) Photochemotherapy of psoriasis with oral methoxysalen and longwave ultraviolet light. N Engl J Med 291: 1207–1211
Roenigk HH, Maibach HI, Weinstein GP (1973) Methotrexate therapy for psoriasis. Arch Dermatol 108: 35–42
Rosinska D, Wolska H, Jablonska S et al. (1988) Etretinate in severe psoriasis of children. Pediatr Dermatol 5: 266–272
Runne U, Kunze J (1982) Short-duration (“minutes”) therapy with dithranol for psoriasis: a new out-patient regimen. Br J Dermatol 106: 135–139
Runne U, Kunze J (1985) Die „Minutentherapie“ der Psoriasis mit Dithranol und ihre Modifikationen. Eine kritische Wertung anhand von 315 Patienten. Hautarzt 36: 4046
Schauder S, Mahrle G (1982) Kombinierte Einstundentherapie der Psoriasis mit Anthralin und UV-Licht. Hautarzt 33: 206–209
Shroot B (1986) Anthralin. Dermatologica 173:261–263 Steigleder GK, Orfanos CE, Pullmann H (1979) RetinoidSUP-Therapie der Psoriasis. Z Hautkr 54: 19–23
Stern RS, Zierler S, Parrish JA (1980) Skin carcinoma in patients with psoriasis treated with topical tar and artificial ultraviolet radiation. Lancet II: 732–735
Stern RS, Lange R, and Members of the Photochemotherapy Follow-up Study. (1988) Non-melanoma skin cancer occurring in patients treated with PUVA five to ten years after first treatment. J Invest Dermatol 91: 120–124
Stoughton RB, DeQuoy P, Walter JF (1978) Crude coal tar plus near ultraviolet light suppresses DNA synthesis in epidermis. Arch Dermatol 114: 43–45
Tanew A, Ortel B, Rappersberger K et al. (1988) 5-methoxypsoralen (Bergapten) for photochemotherapy. Bioavailability, phototoxicity, and clinical efficacy in psoriasis of a new drug preparation. J Am Acad Dermatol 18: 333–338
Wang JTC, Krazmien RJ, Dahlheim CR (1986) Anthralin stain removal. J Am Acad Dermatol 15: 951–955
Weber G, Frey H, Neugebauer D (1985) Neue systemische Therapien der Psoriasis. Hautarzt 36: 20–24
Wolff K (1979) Psoriasis and PUVA. Dtsch Med Wochenschr 104: 1543–1546
Wolff K (1985) Photochemotherapie (PUVA): Pro und Contra. Hautarzt 36: 25–33
Young E (1986) Treatment of psoriasis with dithranol cream compared with dithranol paste. Dermatologica 173: 285–287
Zachariae H (1985) Orale Methotrexattherapie: Pro und Contra. Hautarzt 36: 10–12
Zaun H (1985) Orale Glukokortikosteroidtherapie bei Psoriasis vulgaris: Pro und Contra. Hautarzt 36: 13–15
Pityriasis Rubra Pilaris
Baden HP (1987) Pityriasis rubra pilaris. In: Fitzpatrick TB, Eisen AZ, Wolff K et al. (eds) Dermatology in general medicine, 3rd edn. McGraw-Hill, New York, pp 517–519
Braun-Falco O, Ryckmanns F, Schmoeckel C et al. (1983) Pityriasis rubra pilaris: a clinico-pathological and therapeutic study with special reference to histochemistry, autoradiography, and electron microscopy. Arch Dermatol Res 275: 287–295
Davidson CL, Winkelmann RK, Kierland RR (1969) Pityriasis rubra pilaris — a follow up study of 57 patients. Arch Dermatol 100: 175–183
Goldsmith LA, Weinrich AE, Shupack J (1982) Pityriasis rubra pilaris response to 13-cis-retinoic acid. J Am Acad Dermatol 6: 710–715
Griffiths WAD (1980) Pityriasis rubra pilaris. J Clin Exp Dermatol 5: 105–112
Kint A, de Bie S, Geerts ML et al. (1972) Pityriasis rubra pilaris, a familial condition. Arch Belg Dermatol 158: 371–376
Küster W, Happle R (1985) Genetik der Pityriasis rubra pilaris: Autosomal dominante oder polygene Vererbung? Aktuel Dermatol 11: 25–28
Lauharanta I, Lassus A (1980) Treatment of pityriasis rubra pilaris with an oral aromatic retinoid (RO 10–9159). Acta Derm Venereol (Stockh) 60: 461–462
Marks R, Finlay AY, Holt PJA (1981) Severe disorders of keratinization: effects of treatment with Tigason (etretinate). Br J Dermatol 104: 667–673
Niemi KM, Kousa M, Storgarols K et al. (1976) Pityriasis rubra pilaris. Dermatologica 152: 109–118
Pavlidakey GP, Hashimoto K, Savoy LB et al. (1985) Stanazolol in the treatment of pityriasis rubra pilaris. Arch Dermatol 121: 546–548
Ralfs IG, Dawber RPR, Ryan TJ et al. (1981) Pityriasis rubra pilaris: epidermal cell kinetics. Br J Dermatol 104: 249–252
Randle HW, Diaz-Perez JL, Winkelmann RK (1980) Toxic doses of vitamin A for pityriasis rubra pilaris. Arch Dermatol 116: 888–892
The So-Called Parapsoriasis Group
Altman J (1984) Parapsoriasis: a histopathological review and classification. Semin Dermatol 3: 14–21
Binazzi M (1977) Some research on parapsoriasis and lymphomas. Arch Dermatol Res 258: 17–23
Bonvalet D, Colau-Gohm K, Belaich S et al. (1977) Les différentes formes du parapsoriasis en plaques. A propos de 90 cas. Ann Dermatol Venereol 104: 18–25
Brocq L (1902) Les parapsoriasis. Ann Dermatol 3: 433–468
Degos R, Duperrat B, Daniel F (1966) Le parapsoriasis ulcèro-nécrotique hyperthermique. Forme subaigue du parapsoriasis en gouttes. Ann Dermatol Syph 93: 481–496
Faber WR, Van Joost T (1980) Pityriasis lichenoides, an immune complex disease? Acta Derm Venereol (Stockh) 60: 259–261
Grosshans E (1986) Le parapsoriasis en plaques. Ann Dermatol Venereol 113: 865–867
Habermann R (1925) Über die akut verlaufende, nekrotisierende Unterart der Pityriasis lichenoides (Pityriasis lichenoides et varioliformis acuta). Dermatol Z 45: 42–48
Hood AF, Mark EJ (1982) Histopathologic diagnosis of PLEVA and its clinical correlation. Arch Dermatol 118: 478–482
Hu CH, Winkelmann RK (1973) Digitate dermatosis. A new look at symmetrical small plaque parapsoriasis. Arch Dermatol 107: 65–69
Juliusberg F (1899) Über die Pityriasis lichenoides chronica (psoriasiform-lichenoides Exanthem). Arch Dermatol Syph 50: 359–374
Klug H, Haustein OF (1977) Elektronenmikroskopische Untersuchungen zur Parapsoriasis guttata ( Pityriasis lichenoides chronica ). Dermatol Monatsschr 163: 455–467
Kresbach H (1983) Die sogenannte Parapsoriasisgruppe. In: Braun-Falco O, Burg G (eds) Fortschritte der praktischen Dermatologie und Venerologie, vol 10. Springer, Berlin, pp 13–21
Lambert WB, Everett MA (1981) The posology of parapsoriasis. J Am Acad Dermatol 5: 373–395
Marks R, Black M, Wilson-Jones E (1972) Pityriasis lichenoides: a reappraisal. Br J Dermatol 86: 215–225
Mucha V (1916) Über einen der Parakeratosis variegata (Unna) bzw. Pityriasis lichenoides chronica (Neisser-Juliusberg) nahestehenden eigentümlichen Fall. Arch Dermatol Syph 123: 586–592
Muhlbauer JE, Bhan AK (1984) Immunopathology of PLEVA. J Am Acad Dermatol 10: 783–795
Nasemann T, Markowski R, Jacubowicz K (1966) Zur histologischen Differentialdiagnose der Pityriasis lichenoides et varioliformis acuta Mucha-Habermann. Hautarzt 17: 395–399
Rongioletti F, Rivara G, Rebora A (1987) Pityriasis lichenoides et varioliformis acuta and acquired toxoplasmosis. Dermatologica 175: 41–44
Samman PD (1972) The natural history of parapsoriasis en plaques (chronic superficial dermatitis) and prereticulotie poikiloderma. Br J Dermatol 87: 405–411
Szymanski FJ (1959) Pityriasis lichenoides et varioliformis acuta. Histopathological evidence that it is an entity distinct from parapsoriasis. Arch Dermatol Syphilol 79: 7–16
Truhan AP, Hebert AA, Esterly NB (1986) Pityriasis lichenoides in children: therapeutic response to erythromycin. J Am Acad Dermatol 15: 66–70
Unna PG, Santi DR, Pollitzer S (1890) Über die Parakeratosen im allgemeinen und eine neue Form derselben (Para-keratosis variegata). Monatsh Prakt Dermatol 10: 404412, 444–459
Vella Briffa D, Warin AP, Calnon CD (1979) Parakeratosis variegata: a report of two cases and their treatment with PUVA. Clin Exp Dermatol 4: 537–541
Erythroderma
Abrahams I, McCarthy JT, Sanders SL (1963) 101 cases of exfoliative dermatitis. Arch Dermatol 87: 96–101
Barker LP, Gross P, McCarthy JT (1958) Erythrodermas of infancy. A different clinical study. Arch Dermatol 77: 201–209
Hasan T, Jansén CT (1983) Erythroderma. A follow-up of fifty cases. J Am Acad Dermatol 8: 836–840
Kiessling W, Tritsch H (1959) Die Melano-Erythrodermie mit Kachexie. Arch Klin Exp Dermatol 208: 579–591
Löblich JH, Wagner G (1953) Das pigmentierte Lymphogranulom mit generalisierenden Hauterscheinungen. Arch Dermatol Syph 196: 33–64
Montgomery H (1933) Exfoliative dermatosis and malignant erythroderma. The value and limitations of histopathologic studies. Arch Dermatol Syph 27: 253–274
Nicolis GD, Helwig EB (1973) Exfoliative dermatitis. A clinicopathologic study of 135 cases. Arch Dermatol 108: 788–797
Winkelmann RK, Buechner SA, Diaz-Perez JL (1984) Pre- Sézary syndrome. J Am Acad Dermatol 10: 992–999
Lichen Planus and Lichenoid Eruptions
Abell E, Ramnarain D (1975) Epidermal antigens in lichen planus. Br J Dermatol 92: 631–636
Altman J, Perry HO (1961) The variations and course of lichen planus. Arch Dermatol 84: 179–191
Anderson RL, Cullen SI (1976) Pseudopelade of Brocq secondary to lichen planus. Cutis 17: 916–918
Arndt KA (1987) Lichen planus. In: Fitzpatrick TB, Eisen AZ, Wolff K et al. (eds) Dermatology in general medicine, 3rd edn. McGraw-Hill, New York, pp 967–973
Baart de la Faille-Kuyper EH, Baart de la Faille H (1974) An immunofluorescence study of lichen planus. Br J Dermatol 90: 365–371
Black MM (1977) What is going on in lichen planus. Clin Exp Dermatol 2: 303–310
Cram DL, Kierland RR, Winkelmann RK (1966) Ulcerative lichen planus of the feet. Arch Dermatol 93: 692–701
Crotty CP, Su WDP, Winkelmann RK (1980) Ulcerative lichen planus. Follow-up of surgical excision and grafting. Arch Dermatol 116: 1252–1256
Dahl M (1982) Lichen planus. In: Moschella SL (ed) Dermatology update. Elsevier, Amsterdam, pp 33–51
Ebner H (1973) Untersuchungen über die celluläre Zusammensetzung des Lichen ruber planus-Infiltrates. Arch Dermatol Forsch 247: 309–318
Ebner H, Erlach E, Gebhart W (1973) Untersuchungen über die Blasenbildung beim Lichen ruber planus. Arch Dermatol Forsch 247: 193–205
Faber M (1987) Das entzündliche Infiltrat des Lichen ruber planus unter Etretinattherapie. Aktuel Dermatol 13: 140–141
Fellner MJ (1980) Lichen planus. Int J Dermatol 19: 71–75
Gougerot H, Civatte A (1953) Critéres cliniques et histolo-giques des lichens plans cutanés et muqueux: delimina-tion. Ann Dermatol Syphiligr 80: 5–29
Haber H, Sarkany I (1958) Hypertrophie lichen planus and lichen simplex. Trans St Johns Hosp Dermatol Soc 41: 61–65
Hintner H, Tappeiner G, Hönigsmann H et al. (1979) Lichen planus and bullous pemphigoid. Acta Derm Venereol (Stockh) 59 (Suppl 85): 71–76
Jänner M, Muissus E, Rohde B (1967) Lichen planus als fakultative Präkanzerose. Dermatol Wochenschr 153: 513–518
Katzenellenbogen I (1962) Lichen planus actinicus (lichen planus in subtropical countries). Dermatologica 124: 10–20
Kronenberg K, Fretzing D, Potter B (1971) Malignant degeneration of lichen planus. Arch Dermatol 104: 304–307
Lachapalle JM, de la Brassine M (1973) The proliferation of cells in the dermal infiltrate of lichen planus lesions. Br J Dermatol 89: 137–141
Lowe NJ, Cudworth AG, Woodrow JC (1976) HL-A antigens in lichen planus. Br J Dermatol 95: 169–171
Medenica M, Lorincz A (1977) Lichen planus: an ultra-structural study. Acta Derm Venereol (Stockh) 57: 55–62
Ortonne JP, Schmidt D, Alario A et al. (1979) Oral photo-chemotherapy in lichen planus (LP) and mycosis fungoides (MF): ultrastructural modifications of the infiltrating cells. Acta Derm Venereol (Stockh) 59: 211–218
Plotnick H, Burnham TK (1986) Lichen planus and coexisting lupus erythematosus versus lichen planus-like lupus erythematosus. Clinical, histologic, and immunopathologic considerations. J Am Acad Dermatol 14: 931–938
Powell FC, Rogers RS, Dickson ER et al. (1986) An association between HLA DR1 and lichen planus. Int J Dermatol 114: 473–478
Ragaz A, Ackerman B (1981) Evolution, maturation and regression of lesions of lichen planus. New observations and correlations of clinical and histologic findings. Am J Dermatopathol 3: 5–25
Reinhardt LA, Wilkin JK, Kirkendall WM (1983) Lichen-oid eruption produced by captopril. Cutis 31: 98–102
Saurat JH (1981) Cutaneous manifestations of graft-versus-host disease. Int J Dermatol 20: 249–256
Saurat JH, Gluckman E, Bussel A et al. (1975) The lichen planus-like eruption after bone marrow transplantation. Br J Dermatol 93: 675–681
Saurat JH, Guinepain MT, Sohier DJ et al. (1977) Coexistence d’un lichen plan et d’une pemphigoide bulleuse. Etude en immunofluorescence d’un “lichen pemphigoide”. Ann Dermatol Venereol 104: 368–374
Schmidt H (1961) Frequency, duration and localization of lichen planus. Acta Derm Venereol (Stockh) 41: 164
Sehgal VN, Abraham GIS, Malik GB (1972) Griseofulvin therapy in lichen planus: a double-blind controlled trial. Br J Dermatol 87: 383–385
Shklar P (1968) Erosive and bullous oral lesions of lichen planus. Arch Dermatol 97: 411–416
Silver H, Chargin L, Sachs PM (1953) Follicular lichen planus (lichen planopilaris). Arch Dermatol Syph 67: 346–354
Stankler L (1975) Deficiency of circulating IgA and IgM in adult patients with lichen planus. Br J Dermatol 93: 25–27
Thyresson N, Moberger G (1957) Cytologic studies in lichenruber planus. Acta Derm Venereol (Stockh) 37: 191–20
Woo TY (1985) Systemic isotretinoin treatment of oral and cutaneous lichen planus. Cutis 35: 385–393
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Braun-Falco, O., Plewig, G., Wolff, H.H., Winkelmann, R.K. (1991). Erythematous and Erythematosquamous Skin Diseases. In: Dermatology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-00181-3_14
Download citation
DOI: https://doi.org/10.1007/978-3-662-00181-3_14
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-00183-7
Online ISBN: 978-3-662-00181-3
eBook Packages: Springer Book Archive